|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 1 (July 1), 2000:
pp. 9-23
REVIEW ARTICLE
Fates of human B-cell precursors
Tucker W. LeBien
From the Department of Laboratory Medicine and Pathology, University
of Minnesota Cancer Center, and Center for Immunology, University of
Minnesota, Minneapolis.
Development of mammalian B-lineage cells is characterized by
progression through a series of checkpoints defined primarily by
rearrangement and expression of immunoglobulin genes. Progression through these checkpoints is also influenced by stromal cells in the
microenvironment of the primary tissues wherein B-cell development
occurs, ie, fetal liver and bone marrow and adult bone marrow. This
review focuses on the developmental biology of human bone marrow
B-lineage cells, including perturbations that contribute to
the origin and evolution of B-lineage acute lymphoblastic leukemia and
primary immunodeficiency diseases characterized by agammaglobulinemia.
Recently described in vitro and in vivo models that support development
and expansion of human B-lineage cells through multiple checkpoints
provide new tools for identifying the bone marrow stromal cell-derived
molecules necessary for survival and proliferation. Mutations in genes
encoding subunits of the pre-B cell receptor and molecules involved in
pre-B cell receptor signaling culminate in X-linked and non-X-linked
agammaglobulinemia. A cardinal feature of these immunodeficiencies is
an apparent apoptotic sensitivity of B-lineage cells at the pro-B to
pre-B transition. On the other end of the spectrum is the apoptotic resistance that accompanies the development of B-lineage acute lymphoblastic leukemia, potentially a reflection of genetic
abnormalities that subvert normal apoptotic programs. The triad of
laboratory models that mimic the bone marrow microenvironment,
immunodeficiency diseases with specific defects in B-cell development,
and B-lineage acute lymphoblastic leukemia can now be integrated to
deepen our understanding of human B-cell development.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. E. Johnson, N. Shah, A. A. Bajer, and T. W. LeBien
IL-7 Activates the Phosphatidylinositol 3-Kinase/AKT Pathway in Normal Human Thymocytes but Not Normal Human B Cell Precursors
J. Immunol.,
June 15, 2008;
180(12):
8109 - 8117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kikushige, G. Yoshimoto, T. Miyamoto, T. Iino, Y. Mori, H. Iwasaki, H. Niiro, K. Takenaka, K. Nagafuji, M. Harada, et al.
Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte/Macrophage Progenitor Stages to Maintain Cell Survival
J. Immunol.,
June 1, 2008;
180(11):
7358 - 7367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Hystad, J. H. Myklebust, T. H. Bo, E. A. Sivertsen, E. Rian, L. Forfang, E. Munthe, A. Rosenwald, M. Chiorazzi, I. Jonassen, et al.
Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling
J. Immunol.,
September 15, 2007;
179(6):
3662 - 3671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Barabe, J. A. Kennedy, K. J. Hope, and J. E. Dick
Modeling the Initiation and Progression of Human Acute Leukemia in Mice
Science,
April 27, 2007;
316(5824):
600 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starkova, J. Madzo, G. Cario, T. Kalina, A. Ford, M. Zaliova, O. Hrusak, and J. Trka
The Identification of (ETV6)/RUNX1-Regulated Genes in Lymphopoiesis Using Histone Deacetylase Inhibitors in ETV6/RUNX1-Positive Lymphoid Leukemic Cells
Clin. Cancer Res.,
March 15, 2007;
13(6):
1726 - 1735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Malaspina, S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T.-W. Chun, et al.
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7
PNAS,
February 14, 2006;
103(7):
2262 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Johnson, N. Shah, A. Panoskaltsis-Mortari, and T. W. LeBien
Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells
J. Immunol.,
December 1, 2005;
175(11):
7325 - 7331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sternberg, S. Killick, T. Littlewood, C. Hatton, A. Peniket, T. Seidl, S. Soneji, J. Leach, D. Bowen, C. Chapman, et al.
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome
Blood,
November 1, 2005;
106(9):
2982 - 2991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Randolph
The Neonatal Adaptive Immune System
NeoReviews,
October 1, 2005;
6(10):
e454 - e462.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R.A. Ehrhardt, J. T. Hsu, L. Gartland, C.-M. Leu, S. Zhang, R. S. Davis, and M. D. Cooper
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells
J. Exp. Med.,
September 19, 2005;
202(6):
783 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Hanley, L. A. Napolitano, and J. M. McCune
Growth Hormone-Induced Stimulation of Multilineage Human Hematopoiesis
Stem Cells,
September 1, 2005;
23(8):
1170 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ishikawa, M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice
Blood,
September 1, 2005;
106(5):
1565 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Imamura, T. Miyamoto, G. Yoshimoto, K. Kamezaki, F. Ishikawa, H. Henzan, K. Kato, K. Takase, A. Numata, K. Nagafuji, et al.
Mobilization of Human Lymphoid Progenitors after Treatment with Granulocyte Colony-Stimulating Factor
J. Immunol.,
August 15, 2005;
175(4):
2647 - 2654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kikuchi, H. Shinohara, C. Nonomura, H. Ando, S. Takaku, H. Nojiri, and M. Nakamura
Not core 2 {beta}1,6-N-acetylglucosaminyltransferase-2 or -3 but -1 regulates sialyl-Lewis x expression in human precursor B cells
Glycobiology,
March 1, 2005;
15(3):
271 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Le, M. Honczarenko, A. M. Glodek, D. K. Ho, and L. E. Silberstein
CXC Chemokine Ligand 12-Induced Focal Adhesion Kinase Activation and Segregation into Membrane Domains Is Modulated by Regulator of G Protein Signaling 1 in Pro-B Cells
J. Immunol.,
March 1, 2005;
174(5):
2582 - 2590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hotfilder, S. Rottgers, A. Rosemann, A. Schrauder, M. Schrappe, R. Pieters, H. Jurgens, J. Harbott, and J. Vormoor
Leukemic Stem Cells in Childhood High-Risk ALL/t(9;22) and t(4;11) Are Present in Primitive Lymphoid-Restricted CD34+CD19- Cells
Cancer Res.,
February 15, 2005;
65(4):
1442 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Klein, N. Feldhahn, J. L. Mooster, M. Sprangers, W.-K. Hofmann, P. Wernet, M. Wartenberg, and M. Muschen
Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion, and IGL Gene Rearrangement
J. Immunol.,
January 1, 2005;
174(1):
367 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shah, R. J. Asch, A. S. Lysholm, and T. W. LeBien
Enhancement of stress-induced apoptosis in B-lineage cells by caspase-9 inhibitor
Blood,
November 1, 2004;
104(9):
2873 - 2878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Smith and M. Sigvardsson
The roles of transcription factors in B lymphocyte commitment, development, and transformation
J. Leukoc. Biol.,
June 1, 2004;
75(6):
973 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Klein, N. Feldhahn, L. Harder, H. Wang, M. Wartenberg, W.-K. Hofmann, P. Wernet, R. Siebert, and M. Muschen
The BCR-ABL1 Kinase Bypasses Selection for the Expression of a Pre-B Cell Receptor in Pre-B Acute Lymphoblastic Leukemia Cells
J. Exp. Med.,
March 1, 2004;
199(5):
673 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling
PNAS,
December 9, 2003;
100(25):
15113 - 15118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Reynaud, N. Lefort, E. Manie, L. Coulombel, and Y. Levy
In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells
Blood,
June 1, 2003;
101(11):
4313 - 4321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sanz, M. Alvarez-Mon, C. Martinez-A, and A. de la Hera
Human cord blood CD34+Pax-5+ B-cell progenitors: single-cell analyses of their gene expression profiles
Blood,
May 1, 2003;
101(9):
3424 - 3430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Glodek, M. Honczarenko, Y. Le, J. J. Campbell, and L. E. Silberstein
Sustained Activation of Cell Adhesion Is a Differentially Regulated Process in B Lymphopoiesis
J. Exp. Med.,
February 17, 2003;
197(4):
461 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. N. Cooper, M. S. Topp, L. M. Serrano, S. Gonzalez, W.-C. Chang, A. Naranjo, C. Wright, L. Popplewell, A. Raubitschek, S. J. Forman, et al.
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
Blood,
February 15, 2003;
101(4):
1637 - 1644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Wang, Z. Zhang, P. D. Burrows, H. Kubagawa, S. L. Bridges Jr, H. W. Findley, and M. D. Cooper
V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation
Blood,
February 1, 2003;
101(3):
1030 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimoto, E. Montecino-Rodriguez, H. Leathers, R. P. Stephan, and K. Dorshkind
B-cell development in the thymus is limited by inhibitory signals from the thymic microenvironment
Blood,
November 15, 2002;
100(10):
3504 - 3511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Smith, J. W. Rhee, and M. L. Cleary
Transformation of Bone Marrow B-Cell Progenitors by E2A-HLF Requires Coexpression of BCL-2
Mol. Cell. Biol.,
November 1, 2002;
22(21):
7678 - 7687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Honczarenko, Y. Le, A. M. Glodek, M. Majka, J. J. Campbell, M. Z. Ratajczak, and L. E. Silberstein
CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor
Blood,
September 18, 2002;
100(7):
2321 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Kim, J. Fang, S. Rheingold, R. Aplenc, R. Wasserman, and S. A. Grupp
Cytoplasmic {micro} Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia
Cancer Res.,
August 1, 2002;
62(15):
4212 - 4216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Muschen, S. Lee, G. Zhou, N. Feldhahn, V. S. Barath, J. Chen, C. Moers, M. Kronke, J. D. Rowley, and S. M. Wang
Molecular portraits of B cell lineage commitment
PNAS,
July 23, 2002;
99(15):
10014 - 10019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mikkola, B. Heavey, M. Horcher, and M. Busslinger
Reversion of B Cell Commitment upon Loss of Pax5 Expression
Science,
July 5, 2002;
297(5578):
110 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hotfilder, S. Rottgers, A. Rosemann, H. Jurgens, J. Harbott, and J. Vormoor
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal
Blood,
June 28, 2002;
100(2):
640 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Panzer-Grumayer, K. Fasching, S. Panzer, K. Hettinger, K. Schmitt, S. Stockler-Ipsiroglu, and O. A. Haas
Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis
Blood,
June 17, 2002;
100(1):
347 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gisler and M. Sigvardsson
The Human V-PreB Promoter Is a Target for Coordinated Activation by Early B Cell Factor and E47
J. Immunol.,
May 15, 2002;
168(10):
5130 - 5138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Wang, R. P. Stephan, A. Scheffold, D. Kunkel, H. Karasuyama, A. Radbruch, and M. D. Cooper
Differential surrogate light chain expression governs B-cell differentiation
Blood,
April 1, 2002;
99(7):
2459 - 2467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Bertrand, C. Vogtenhuber, N. Shah, and T. W. LeBien
Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein
Blood,
December 1, 2001;
98(12):
3398 - 3405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Storek, D. Wells, M. A. Dawson, B. Storer, and D. G. Maloney
Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation
Blood,
July 15, 2001;
98(2):
489 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shah, L. Oseth, H. Tran, B. Hirsch, and T. W. LeBien
Clonal Variation in the B-Lineage Acute Lymphoblastic Leukemia Response to Multiple Cytokines and Bone Marrow Stromal Cells
Cancer Res.,
July 1, 2001;
61(13):
5268 - 5274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bennaceur-Griscelli, C. Pondarre, V. Schiavon, W. Vainchenker, and L. Coulombel
Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history
Blood,
January 15, 2001;
97(2):
435 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Puch, S Armeanu, C Kibler, K. Johnson, C. Muller, M. Wheelock, and G Klein
N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation
J. Cell Sci.,
January 4, 2001;
114(8):
1567 - 1577.
[Abstract]
[PDF]
|
 |
|
| |